Snooping is one of the oldest peccadilloes of man, observes Ambassador M K Bhadrakumar.
The government regulates prices of all other medicines.
The successful implementation of the new Act will depend on a much bigger involvement of the state through a huge new superstructure of registration, certification and supervision
.jpg)
In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.
Under the current administration, political attitudes toward IP seem to have improved.
'The hour is very late, and the choice between triumph and tragedy knocks at our door,' says Ajay Shah.
A federal body began a hearing on the impact of Indian trade policies on US businesses wherein American bodies and advocacy groups slammed India for its trade practices, alleging they hit their jobs and business.
Roadblocks ahead as these medicines could face new clinical tests, more scrutiny
''There is the perennial worry in the Indian mind regarding the US 'hyphenating' India and Pakistan. Frankly, this is a completely nonsensical hypothesis. The US has always 'hyphenated' India and Pakistan and it couldn't have been otherwise,' says Ambassador M K Bhadrakumar.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances